N-acetylcysteine versus placebo for treating nail biting, a double blind randomized placebo controlled clinical trial

Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry

Volumn 12, Issue 3, 2013, Pages 223-228

  Ghanizadeh, Ahmad ^a,b   Derakhshan, Nima ^b   Berk, Michael ^c,d  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c DEAKIN UNIVERSITY   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Children; Impulsive; N acetylcysteine; Nail biting; Obsessive compulsive

Indexed keywords

ACETYLCYSTEINE; ATOMOXETINE; BIPERIDEN; CITALOPRAM; FLUOXETINE; METHYLPHENIDATE; NORTRIPTYLINE; PIMOZIDE; PLACEBO; RISPERIDONE; THIORIDAZINE;

ADOLESCENT; ADULT; AGGRESSION; AGITATION; ANTHROPOMETRIC PARAMETERS; ARTICLE; BRUXISM; CHILD; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG WITHDRAWAL; ENURESIS; FEMALE; HABIT; HEADACHE; HUMAN; MAJOR DEPRESSION; MALE; MENTAL DISEASE; NAIL LENGTH; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

ACETYLCYSTEINE; ADOLESCENT; CHILD; CHRONIC DISEASE; COMORBIDITY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; NAIL BITING;

EID: 84881545376     PISSN: 18715230     EISSN: 1875614X     Source Type: Journal    
DOI: 10.2174/1871523011312030003     Document Type: Article

References (34)

1. Ghanizadeh, A.; Shekoohi, H., Prevalence of nail biting and its association with mental health in a community sample of children. BMC Res. Notes, 2011, 4, (1), 116.
2. Feteih, R.M., Signs and symptoms of temporomandibular disorders and oral parafunctions in urban Saudi Arabian adolescents: a research report. Head Face Med., 2006, 2, 25.
3. Tanaka, O.M.; Vitral, R.W.; Tanaka, G.Y.; Guerrero, A.P.; Camargo, E.S., Nailbiting, or onychophagia: a special habit. Am.J.Orthod. Dentofacial Orthop., 2008, 134, (2), 305-308.
4. Ghanizadeh, A., Nail biting; etiology, consequences and management. Iran J.Med. Sci., 2011, 36, (2), 73-79.
5. Pacan, P.; Grzesiak, M.; Reich, A.; Szepietowski, J.C., Onychophagia as a spectrum of obsessive-compulsive disorder. Acta Derm. Venereol, 2009, 89, (3), 278-280.
6. Sousa, D.; Pinto, D.; Araujo, R.; Rego, R.O.; Moreira-Neto, J., Gingival abscess due to an unusual nail-biting habit: a case report. J.Contemp. Dent. Pract., 2010, 11, (2), 085-091.
7. Bello, J.; Nunez, F.A.; Gonzalez, O.M.; Fernandez, R.; Almirall, P.; Escobedo, A.A., Risk factors for Giardia infection among hospitalized children in Cuba. Ann. Trop. Med. Parasitol., 2011, 105, (1), 57-64.
8. Burkhart, C.N.; Burkhart, C.G., Assessment of frequency, transmission, and genitourinary complications of enterobiasis (pinworms). Int.J. Dermatol., 2005, 44, (10), 837-840.
9. Sung, J.F.; Lin, R.S.; Huang, K.C.; Wang, S.Y.; Lu, Y.J., Pinworm control and risk factors of pinworm infection among primary-school children in Taiwan. Am. J.Trop. Med. Hyg., 2001, 65, (5), 558-562.
10. de Berker, D., Childhood nail diseases. Dermatol. Clin., 2006, 24, (3), 355-363.
11. Ghanizadeh, A.; Mosallaei, S., Psychiatric disorders and behavioral problems in children and adolescents with Tourette syndrome. Brain Dev., 2009, 31, (1), 15-19.
12. Ghanizadeh, A., Association of nail biting and psychiatric disorders in children and their parents in a psychiatrically referred sample of children. Child Adolesc. Psychiatry Ment. Health, 2008, 2, (1), 13.
13. Ravindran, A.V.; da Silva, T.L.; Ravindran, L.N.; Richter, M.A.; Rector, N.A., Obsessive-compulsive spectrum disorders: a review of the evidence-based treatments. Can. J. Psychiatry, 2009, 54, (5), 331-343.
14. Dean, O.M.; Bush, A.I.; Berk, M., Translating the Rosetta Stone of N-acetylcysteine. Biol. Psychiatry, 2012, 71, (11), 935-936.
15. Sansone, R.A.; Sansone, L.A., Getting a Knack for NAC: NAcetyl- Cysteine. Innov. Clin. Neurosci., 2011, 8, (1), 10-14.
16. Dodd, S.; Dean, O.; Copolov, D.L.; Malhi, G.S.; Berk, M., Nacetylcysteine for antioxidant therapy: pharmacology and clinical utility. Expert. Opin. Biol. Ther., 2008, 8, (12), 1955-1962.
17. Berk, M.; Copolov, D.; Dean, O.; Lu, K.; Jeavons, S.; Schapkaitz, I.; Anderson-Hunt, M.; Judd, F.; Katz, F.; Katz, P.; Ording- Jespersen, S.; Little, J.; Conus, P.; Cuenod, M.; Do, K.Q.; Bush, A.I., N-acetyl cysteine as a glutathione precursor for schizophrenia- -a double-blind, randomized, placebo-controlled trial. Biol. Psychiatry, 2008, 64, (5), 361-368.
18. Lavoie, S.; Murray, M.M.; Deppen, P.; Knyazeva, M.G.; Berk, M.; Boulat, O.; Bovet, P.; Bush, A.I.; Conus, P.; Copolov, D.; Fornari, E.; Meuli, R.; Solida, A.; Vianin, P.; Cuenod, M.; Buclin, T.; Do, K.Q., Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients. Neuropsychopharmacology, 2008, 33, (9), 2187-2199.
19. Berk, M.; Copolov, D.L.; Dean, O.; Lu, K.; Jeavons, S.; Schapkaitz, I.; Anderson-Hunt, M.; Bush, A.I., N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial. Biol.Psychiatry, 2008, 64, (6), 468-475.
20. Berk, M.; Dean, O.; Cotton, S.M.; Gama, C.S.; Kapczinski, F.; Fernandes, B.S.; Kohlmann, K.; Jeavons, S.; Hewitt, K.; Allwang, C.; Cobb, H.; Bush, A.I.; Schapkaitz, I.; Dodd, S.; Malhi, G.S., The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: An open label trial. J. Affect.Disord.,2011, 135, 389-394.
21. Magalhaes, P.V.; Dean, O.M.; Bush, A.I.; Copolov, D.L.; Malhi, G.S.; Kohlmann, K.; Jeavons, S.; Schapkaitz, I.; Anderson-Hunt, M.; Berk, M., N-acetylcysteine for major depressive episodes in bipolar disorder. Rev. Bras. Psiquiatr., 2011, 33, (4), 374-378.
22. Karila, L.; Gorelick, D.; Weinstein, A.; Noble, F.; Benyamina, A.; Coscas, S.; Blecha, L.; Lowenstein, W.; Martinot, J.L.; Reynaud, M.; Lepine, J.P., New treatments for cocaine dependence: a focused review. Int.J. Neuropsychopharmacol, 2008, 11, (3), 425-438.
23. Reichel, C.M.; Moussawi, K.; Do, P.H.; Kalivas, P.W.; See, R.E., Chronic N-acetylcysteine during abstinence or extinction after cocaine self-administration produces enduring reductions in drug seeking. J. Pharmacol. Exp. Ther., 2011, 337, (2), 487-493.
24. Grant, J.E.; Kim, S.W.; Odlaug, B.L., N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study. Biol. Psychiatry, 2007, 62, (6), 652-657.
25. Schmaal, L.; Berk, L.; Hulstijn, K.P.; Cousijn, J.; Wiers, R.W.; van den Brink, W., Efficacy of N-acetylcysteine in the treatment of nicotine dependence: a double-blind placebo-controlled pilot study. Eur. Addict. Res., 2011, 17, (4), 211-216.
26. Grant, J.E.; Odlaug, B.L.; Kim, S.W., N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a doubleblind, placebo-controlled study. Arch. Gen. Psychiatry, 2009, 66, (7), 756-763.
27. Ghanizadeh, A.; Derakhshan, N., N-acetylcysteine for treatment of autism, a case report. Journal of Research in Medical Sciences, 2012, 17, (10).
28. Berk, M.; Dean, O.M.; Cotton, S.M.; Gama, C.S.; Kapczinski, F.; Fernandes, B.; Kohlmann, K.; Jeavons, S.; Hewitt, K.; Moss, K.; Allwang, C.; Schapkaitz, I.; Cobb, H.; Bush, A.I.; Dodd, S.; Malhi, G.S., Maintenance N-acetyl cysteine treatment for bipolar disorder: A double-blind randomised placebo controlled trial. BMC Med., 2012, 10, (1), 91.
29. Berk, M.; Jeavons, S.; Dean, O.M.; Dodd, S.; Moss, K.; Gama, C.S.; Malhi, G.S., Nail-biting stuff? The effect of N-acetyl cysteine on nail-biting. CNS Spectr., 2009, 14, (7), 357-360.
30. Ghanizadeh, A.; Mohammadi, M.R.; Yazdanshenas, A., Psychometric properties of the Farsi translation of the Kiddie Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version. BMC Psychiatry, 2006, 6, 10.
31. Twohig, M.P.; Woods, D.W., Evaluating the duration of the competing response in habit reversal: a parametric analysis. J. Appl.Behav. Anal., 2001, 34, (4), 517-520.
32. Odlaug, B.L.; Grant, J.E., N-acetyl cysteine in the treatment of grooming disorders. J.Clin.Psychopharmacol, 2007, 27, (2), 227-229.
33. Leonard, H.L.; Lenane, M.C.; Swedo, S.E.; Rettew, D.C.; Rapoport, J.L., A double-blind comparison of clomipramine and desipramine treatment of severe onychophagia (nail biting). Arch Gen Psychiatry, 1991, 48, (9), 821-827.
34. Ghanizadeh, A.; Bazrafshan, A.; Firoozabadi, A.; Dehbozorgi, G., Habit reversal versus object manipulation training for treating nail biting, a randomized controlled clinical trial. Iran J. Psychiatry, Undre Press.